https://www.selleckchem.com/pr....oducts/blebbistatin.
ients in phenotype 3 who received hydrocortisone had more vasoactive-free days than those who did not (23 days vs 18 days; P for interaction .001), whereas patients in other phenotypes who received hydrocortisone either had no difference or had less vasoactive-free days. In this study, data-driven phenotyping in critically ill children with MODS uncovered 4 distinct and reproducible phenotypes with prognostic relevance and possible therapeutic relevance. Further validation and characterization of these phenotypes is warranted.